Status:
COMPLETED
Reduction of Adverse Events of Anticholinergic Drugs by Multidisciplinary Medical Reviews in Norwegian Nursing Homes
Lead Sponsor:
Ullevaal University Hospital
Collaborating Sponsors:
South-Eastern Norway Regional Health Authority
Norwegian Directorate of Health
Conditions:
Anticholinergic Side Effects
Eligibility:
All Genders
Phase:
NA
Brief Summary
Thesis: Is drug-induced anticholinergic activity additive resulting in a total anticholinergic load causing harmful side effects in old, fragile patients? Is it possible to reduce the anticholinergic ...
Detailed Description
Several studies have claimed that drugs showing anticholinergic activity in vitro cause high levels of serum anticholinergic activity in vivo that might cause impaired cognitive and functional functio...
Eligibility Criteria
Inclusion
- Long-term nursing home patients with none, mild or moderate dementia (evaluated by CDR9,using drugs with a total anticholinergic burden that might lead to adverse events.
Exclusion
- Not able to perform the testes because of physical or psychiatric illnesses.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT00854438
Start Date
September 1 2008
End Date
September 1 2009
Last Update
June 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ullevaal University Hospital
Oslo, Oslo County, Norway, 0407